ITMCTR2100005397
Not yet recruiting
Phase 4
A randomized, parallel controlled clinical trial of honeysuckle oral liquid in the treatment of children with Hand-foot- and- mouth Disease invading lung and spleen
Enshi Tujia and Miao Autonomous Prefecture Central Hospital0 sitesTBD
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Enshi Tujia and Miao Autonomous Prefecture Central Hospital
- Status
- Not yet recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\) Over 0\.5 years old, regardless of gender;
- •2\) Comply with the diagnostic criteria for hand, foot and mouth disease specified in the guidelines for diagnosis and treatment of hand, foot and mouth disease (2018 Edition) issued by the general office of the National Health Commission; The TCM syndrome differentiation of damp heat and toxin excess syndrome in line with the clinical diagnosis and treatment guide of Pediatrics of traditional Chinese medicine. Hand, foot and mouth disease.
- •3\) The course of disease was 24\-48 hours and no other antiviral drugs were used before treatment;
- •4\) Those who voluntarily sign the informed consent form.
Exclusion Criteria
- •1\) Age \< 0\.5 years
- •2\) Exclude diseases that need to be distinguished from hand, foot and mouth disease, such as atypical measles, rubella, infant emergency rash, chickenpox / herpes zoster and papular urticaria.
- •3\) Headache and vomiting; Mental retardation, drowsiness, easily startled, delirium and any other manifestations of nervous system involvement;
- •Limb shaking, muscle clonus, nystagmus, ataxia, eye movement disorder;
- •Weakness or acute flaccid paralysis;
- •Symptoms of convulsion and meningeal irritation, weakening or disappearance of tendon reflex, frequent convulsions, coma, hernia, dyspnea, cyanosis, bloody sputum, pulmonary rales, shock and other circulatory dysfunction, etc.
- •4\) Children with severe primary diseases such as heart, cerebrovascular, liver, kidney and hematopoietic system and mental illness;
- •5\) With pharyngeal conjunctivitis, acute obstructive laryngotracheal bronchitis, bronchiolitis, pneumonia, active tuberculosis, bronchiectasis or other basic lung diseases;
- •6\) Those who have used other Chinese and Western drugs for the treatment of the disease within 48 hours (such as glucocorticoid, human gamma globulin, interferon, traditional Chinese medicine, etc.);
- •7\) Those who have known a history of allergy to the components of this drug, and those who have allergies to food and more than 2 drugs;
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Evaluation of analgesic efficacy of ESP block versus TPV block in patients undergoing tissue expander breast reconstructiobreast cancerJPRN-UMIN000039700Hiroshima University Hospital Department of Anesthesiology40
Completed
Phase 3
A clinical investigation of the extrinsic stain removal efficacy of Colgate total advanced fresh tooth paste as compared to crest regular tooth paste.Health Condition 1: R688- Other general symptoms and signsHealth Condition 2: R688- Other general symptoms and signsHealth Condition 3: Y992- Volunteer activityHealth Condition 4: Y992- Volunteer activityCTRI/2007/091/000002SDM College of Dental sciences80
Completed
Phase 3
A clinical investigation of the efficacy of Anchor tooth paste on dental hypersensitivity as compared to Colgate tooth pasteHealth Condition 1: Y998- Other external cause statusHealth Condition 2: R688- Other general symptoms and signsHealth Condition 3: Y992- Volunteer activityCTRI/2007/091/000009Anchor Health and Beauty care pvt Ltd80
Active, not recruiting
Not Applicable
Effectiveness evaluation of Nystatin gel and suspension for the treatment of candidiasis in the mouth by comparing with Mycostatin suspension.aboratory confirmed efficacy of Nystatin in pharmaceutical forms for buccal use, in patients with oropharyngeal candidiasisTherapeutic area: Diseases [C] - Bacterial Infections and Mycoses [C01]EUCTR2013-003784-56-CZVUAB Pharma a.s.
Completed
Phase 2
The randomized double-blinded controlled trial of Kparviflora versus Betahistine in treating chronic vertigenous patientschronic vertigochronic dizzinessvertigodizzinesschronic vertigoTCTR20220829001Argricultural Research Development Agency (Public Organization)38